|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
WDAY | WILMINGTON PHILIP W | co-President | Jan 16 | Sale | 110.56 | 4,659 | 515,095 | 242,810 | Jan 18 08:28 PM |
WDAY | WILMINGTON PHILIP W | co-President | Dec 15 | Sale | 102.68 | 11,430 | 1,173,613 | 247,469 | Dec 19 05:50 PM |
WDAY | WILMINGTON PHILIP W | co-President | Oct 16 | Sale | 107.31 | 5,160 | 553,709 | 258,899 | Oct 18 07:19 PM |
WDAY | WILMINGTON PHILIP W | co-President | Sep 15 | Sale | 104.40 | 11,435 | 1,193,866 | 264,059 | Sep 19 05:43 PM |
WDAY | WILMINGTON PHILIP W | co-President | Jul 17 | Sale | 102.77 | 5,148 | 529,041 | 275,494 | Jul 19 09:05 PM |
WDAY | WILMINGTON PHILIP W | co-President | Jun 15 | Sale | 98.03 | 19,059 | 1,868,301 | 280,642 | Jun 19 08:02 PM |
WDAY | WILMINGTON PHILIP W | co-President | Apr 17 | Sale | 83.16 | 12,949 | 1,076,825 | 299,701 | Apr 18 08:00 PM |
WDAY | WILMINGTON PHILIP W | co-President | Mar 15 | Sale | 82.89 | 15,631 | 1,295,622 | 246,348 | Mar 17 06:48 PM |
WDAY | WILMINGTON PHILIP W | co-President | Jan 11 | Sale | 80.48 | 8,472 | 681,787 | 261,979 | Jan 13 06:05 PM |
WDAY | WILMINGTON PHILIP W | co-President | Dec 15 | Sale | 68.85 | 7,160 | 492,942 | 270,451 | Dec 19 07:47 PM |
WDAY | WILMINGTON PHILIP W | co-President | Sep 15 | Sale | 87.04 | 7,123 | 619,972 | 286,119 | Sep 19 07:37 PM |
WDAY | WILMINGTON PHILIP W | co-President | Sep 16 | Sale | 88.49 | 8,508 | 752,888 | 277,611 | Sep 19 07:37 PM |
WDAY | WILMINGTON PHILIP W | co-President | Jun 15 | Sale | 79.85 | 36,818 | 2,939,754 | 293,242 | Jun 17 06:16 PM |
WDAY | WILMINGTON PHILIP W | co-President | Mar 15 | Sale | 69.83 | 14,278 | 997,024 | 237,381 | Mar 17 08:25 PM |
WDAY | WILMINGTON PHILIP W | co-President | Mar 16 | Sale | 70.85 | 19,997 | 1,416,826 | 217,384 | Mar 17 08:25 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite